BioAdaptives Inc (BDPT)

[powerbattles]

That is nonsense! Read my DD below, I even copy the last page you mention. It's all there. You can't comprehend financial statement. That noted is old they now clean out old note issues for the spin-off. Nonconvertible notes issued in fiscal year 2023.

I CALL THE TA YESTERDAY & TODAY: Madison Stock Transfer Inc.
Transfer Agent
2500 Coney Island Avenue
Sub Level
Brooklyn, NY 11223
718-627-4453

The outstanding shares amount has increased, as indicated at the bottom of this page. At this moment, I would like to highlight some crucial factors regarding the management and note issues. I have extensively researched the filings, starting from the inception of the company up until the present day. Given that I view this stock as an investment, my research has been thorough to ensure that my decision is the right one for myself and my family.

Please note that my input is solely my opinion and I am not attempting to influence your decision to buy or sell the stock. The choice is yours. I have simply presented all the information I have gathered so that we can have a clear understanding of the stock's situation. Did you know that the CEO, and officers or directors of $BDPT have not received any compensation since 2018? Additionally, they have not earned any stock options, retirement benefits, pension plans, or profit-sharing programs for the benefit of directors, officers, or other employees. This speaks volumes about the character of the management team at $BDPT. You don't see this at all on the OTC Market or even in the entire stock market industry.

If you take a look at their biographies, you will find that they are highly accomplished professionals. They have already achieved success and retired, yet they have chosen to work without pay for the past 5 years to fulfill their legacy. It logically suggests that they are onto something big, something significant enough for them to sacrifice their retirement and work without compensation. Therefore, it is crucial to reconsider any assumptions about why they would dilute the stock or jeopardize their legacy.

ITEM 6. EXECUTIVE COMPENSATION.

As of September 2018 and until the Company acquires additional capital, it is not anticipated that any officer or director will receive salary compensation from the Company other than reimbursement for out-of-pocket expenses incurred on behalf of the Company.

The Company has no stock option, retirement, pension, or profit-sharing programs for the benefit of directors, officers or other employees, but our officers and directors may recommend adoption of one or more such programs in the future.

The screenshots of the tables from 2018 and the present date. I can see that the amounts listed, ranging from $95,000 to $166,000 and $50,000, have remained unchanged. It appears that these amounts represent the working capital allocated to the company and are likely expected as part of the convertible note issue that originated in 2018.
Based on the information provided, it seems that these notes, totaling $347,336, are not considered toxic notes. Therefore, it is unlikely that they would create any problems for us. It's important to consider this information as we assess the financial situation and outlook of the company.



UNCHANGED FROM YESTERDAY: THE TA STATED AS OF TODAY O/S 576,464,023

otcmarkets.com report o/s 422,991,798 as of 05/31/2023 that is 153,472,432 new shares increased.
Upon further examination, I have discovered that the conversion of shares amounts to 132,382,517 shares. If we also consider the addition of restricted shares, the total figure should align with what TA announced. Clearly, they close the book sets out issuances during the period from July 1, 2022 to and including September 30, 2022.
While I cannot predict if there will be any further note issues in the next quarter, it is evident from their past actions that they have made efforts to maintain control over the outstanding shares. Therefore, at this point, I can confidently state that the process is complete and there are no further outstanding matters to address.


Update from hesontheloose
FYI - Just got an email reply from Robert Ellis (president and director)…they’re aware of the interest and shareholder inquiries. He thanked me for my input as well. Response was very by the book/professional. I’d keep an eye out for filings/PR’s in the coming days/weeks. **wink wink** ~ I truly believe we got a real good one here… $BDPT
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172175560